Healthcare -
Biotechnology - NASDAQ - US
$ 1.475
3.4 %
$ 22.1 M
Market Cap
-0.58
P/E
LGVN - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss LGVN - Longeveron Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR